Questions discussed in this category
How do you "have the talk" in a way that is straightforward without emotionally crushing the patient?
I've seen a handful of fatal radiation pneumonitis associated with rapid steroid tapers by the non-treating physicians. How do you recommend prescribi...
What would your approach be in a patient with a mid-esophageal squamous cell carcinoma treated with chemoradiation therapy followed by surgery, with P...
My experience has been that patients can be neurologically devastated years out from WBRT. In Medical Oncology practice at my institution, we do not r...
How often are you scanning the brain and what is your trigger to treat?
While I am encouraged by the results of the LUMINA trial with respect to identifying patients who are less likely to benefit from radiation therapy wh...
What precautions can be taken to limit infestation of the department?
Do you implement a treatment delay and if so how do you decide when...
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice...
Is prior Ra-223 a contraindication for treatment?
Patient has ED unresponsive to cialis/viagra; would you recommend testosterone replacement therapy?
If you do recommend adjuvant therapy, what regimen would you use?
The said patient has been on Imatinib for 2.5 years and is In MMR. Last rt-PCR was 0.04.
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
Would you biopsy lymph node to confirm recurrence/histology?
If confirmed, how do you decide between RT vs chemotherapy? If chemo - BEP x3 vs E...
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
...
I recently saw a patient who had been treated with concurrent pembrolizumab-RT elsewhere. Is this an acceptable practice outside the setting of a clin...
Do you have a preference for bicalutamide? Can abiraterone be used instead?
What if Medical Oncology wants to give more systemic therapy and further delay XRT start date?What should we be telling the Breast/Plastic surgeon/Med...
At what PSA would you become suspicious for biochemical recurrence and pursue restaging? Is there a threshold value?
What imaging modality would you ...
Would you use it for initial staging or at time of biochemical recurrence?
If radiation, what type? EBRT or brachytherapy? Any other techniques you would recommend, such as rectal balloon?
The Intergroup 0162 trial did not demonstrate noninferiority, although OS difference only 5.1 vs. 5.8 yrs. Would pattern of spread affect your d...
Stage is cT4N2M0.
NGS without any actionable mutations and PD-L1 TPS 15%.
Would you offer chemotherapy, radiation, or immunotherapy and, if so, in what order?
Weekly (20 mg/m2 D1, D2) and q 3 wks (70 mg/m2 x 3c or 100 mg/m2 x 3c) regimens have all been listed as acceptable. For reference, RTOG 97&...
Is this an artifact of what agent prior clinical trials used or something to do with mechanism of action (ie less mineralocorticoid effect of dex)?
Assuming no overlap with prior RT doses, would a history of necrosis cause you to hypofractionate rather than deliver single fraction SRS?
Is it reasonable to dose de-escalate since survival will likely depend on the metastatic lung cancer?
Would you consider boosting the nodes? What dose? Would this change your recommendation for length of ADT?
What is the impact among patients and providers?
Has your documentation been adjusted now that patients can readily review?
Do you routinely offer post-operative adjuvant radiation in addition to chemotherapy?
Are the results of the recently published negative phase ...
E.g. One NSCLC with N2 disease, and additional ipsilateral small nodule that is a biopsy-proven second primary. When do you consider SBRT to a nodule ...
Given multidisciplinary discussion has occurred and SBRT has been agreed upon as local therapy, how do you approach the presence of moderate/significa...
Are you offering patients beta-emitters (Samarium-153 lexidronam, strontium-89) to any patients?
Are there clinical features (post-op PSA, Decipher score, pN+, pT3, etc) that would inform your decision?
40 yo adult patient with a~6cm mass with concern for skull base bony involvement (group III and stage III, no nodal involvement )
Do you worry about false negatives on PET, CT, MRI if ADT is started before the scan? Scheduling scans can sometimes book 2-4 weeks out.
Do you allow pre-RT treatment with the CDK 4/6i and hold during RT, vs. allow concurrent with breast/chest wall RT, vs. delay starting CDK 4/6i until ...
If multi-agent systemic therapy, i.e. FOLFIRINOX, is also planned, is there a preferred sequence of therapies?
Resected small bilateral tonsil SCC & base of tongue SCC.
The patient received 6 cycles of BEP 30 years ago for testicular cancer, and suffers fr...
Has your practice changed based on the randomized, phase 3 study showing prophylactic gabapentin is not effective?
Please share your thoughts and exp...
NCCN recommends perioperative FLOT or FOLFOX vs. neoadjuvant chemoRT with Carboplatin/Paclitaxel or FOLFOX.Does CM-577 and the approval of nivolumab p...
What about for a patient with complete radiographic response who declines surgical management?
For patients who were not neoadjuvantly on pembrolizumab, is it safe to initiate it concurrently with radiation?
Does severity of dementia play a factor in recommending ADT?
In elderly patients (>70-75) with a good performance status, does the risk of neurocognitive decline outweigh the benefit of PCI?
Is there a role of EBRT to the prostate with extended fields to cover the retroperitoneal nodes plus ADT (definitive therapy) or would you treat as ca...
Would you do consolidation radiation or active surveillance?
Would presence of variant histology change your recommendation?
In light of updated monarchE trial data, it seems a SLNB would help delineate adjuvant treatment options in this population. However, Choosing Wisely ...
How do you counsel patients on the benefit of adjuvant therapy who thought surgical resection was curative?
If the patient cannot tolerate methotrexate or further chemotherapy, how effective is radiation therapy (e.g. WBRT) in rendering the patient disease-f...
For stroke-like migraine attacks after radiation therapy (SMART syndrome), does your management of these patient's change with recurrent episodes? How...
Would you favor the use of any particular biologics over others?
If so, when do you consider this?
What would be the treatment duration if using oral TKI?
What clinical criteria would make you prefer TORS as the initial treatment approach?
CheckMate 577 only included patients with R0 resection.For R1 resections, guidelines suggest observation vs re-resection only.
How do you stage? Like nasopharynx or p16+ oropharynx?
Do you treat it like npx ca with chemo xrt + adj chemo or like opx p16+ with definitive chemo ...
If yes, do you recommend it be given concurrently with chemotherapy or sequentially? What is your target volume and dose?
Based on the SCORAD III trial, will you now be treating patients with spinal cord compression with single-fraction radiotherapy? Is there anyone ...
Do you try to keep Hb> 10 or 12? Or somewhere in between?
What would be your radiation volumes/dose and choice of chemotherapy?
E.g. disease burden causing airway or vascular compression.
Are there other high or very high risk features that would also contribute to your decision making?
CNS recurrence occurred within two years of prior neoadjuvant therapy
Do you treat with radiation therapy and what dose do you use? What dose do you accept to the duodenum?
NSABP B51 and B52 specifically prohibit this.
Lymph node is 4.5cm with no reported ECE. Does the size of the LN or presence or absence of ECE affect your decision?
Would you offer adjuvant RT or chemotherapy? If so, what chemotherapy would you prefer?
Given that prophylactic cranial irradiation (PCI) has been shown to decrease the incidence of symptomatic brain metastases in patients with extensive ...
Should patients with moderate penetrance pathogenic variants be managed similar to BRCA patients and consider risk reducing contralateral mastectomy?&...
GS 4+4. PSA low (1-2). CT and bone scan negative for lymphadenopathy or metastatic disease. Prostate MRI pending.
The recommended concurrent chemotherapy regimens (cisplatin/paclitaxel and cisplatin/FU) in NCCN are based on BID fractionation of radiation as in RTO...
Can the ipsilateral supraclavicular field and bilateral hilar nodes still be limited stage?
Patient previously had prostatectomy and salvage RT
Would you recommend surgery first or neoadjuvant therapy such as concurrent cisplatin/RT or another regimen?
How do you balance the risk of an EGFR flare while holding osimertinib vs the risk of pneumonitis when continuing?
Did you change your practice given the SRE results in the control arm of EORTC 1333 at ASCO 2021?
When using bisphosphonates or denosumab, what dosin...
Do you allow patients with breast cancer on tamoxifen to use black cohosh?
Are two negative pleurocentesis' adequate to conclude that the patient does not have metastatic disease? Do you routinely recommend VATS and pleural b...
Colleagues in surgery have raised concerns about post radiation effects in the pelvis with the ordering of short course RT->chemo ->surgery.
Any role for surgical extirpation vs systemic treatment?
Is there any role for denosumab? How do you counsel patients regarding the benefit of bisphosphonates on breast cancer outcomes?
In a patient who would be otherwise fit for surgery +/- adjuvant RT, and the delay is caused by COVID-related OR staffing issues, what would be your a...
Does patient age effect your approach?
Would you consider RPLND for any patients in light of the phase II SEMS trial presented at the 2021 ASCO GU Ca...
Do you prefer WBRT, IT chemo or targeted systemic therapy and what is your preference on the sequence of therapies?
Patient is <60 years old
Would there be any benefit to surgery in a healthy/good PS patient? There is so little data on pulmonary atypical carcinoid and radiation respons...
E.g. for a 7cm central NSCLC, would you offer 8 fx SBRT or ChemoRT? Patient is not a surgical candidate.
One example of this scenario would be a patient receiving consolidative durvalumab after chemoRT for stage III NSCLC who develops a new peripheral lun...
Do you consider the small, but statistically significant, improvement in OS to outweigh the side effects of treatment?
Length of temozolomide course when given with adjuvant radiotherapy
Does the answer change on proximity/distance from breast (i.e. what if pelvis or lower extremity?)
https://pubmed.ncbi.nlm.nih.gov/34077237/
What doses and constraints do you use?
If a patient has a large femoral metastasis that cannot be resected, but is to be stabilized with ORIF which will push tumor into the distal end of th...
Does the site of treatment factor into your decision?
Is there any role of radiation therapy for these patient for symptomatic relief?
Performance status is excellent. Second surgical opinion has also confirmed need for amputation, as the recurrence is now breaching intra and extra ar...
History of CDH1 mutation and prophylactic gastrectomy in 2017 - no other primary site found beyond vagina at diagnosis.
Vaginal tumor completely resp...
Can chemoradiation be curative without maximal debulking TURBT?
Post-treatment PET/CT and MRI Pelvis at 3 months showed near resolution of iliac and inguinal lymphadenopathy but new avid retroperitoneal lymph nodes...
In follow up to @Jacqueline Casillas presentation at ASCO 2021 regarding models of survivorship care delivery for AYA patients.
Colloid is a rare histologic subtype and considered to have more favorable outcomes compared with usual ductal adenocarcinoma, but no dedicated prospe...
Gleason 4+3=7 and PSA 4
Previously received pelvic EBRT and intracavitary brachytherapy. IORT was administered to the node-positive side wall at the time of exenteration.
This patient had resection of the primary, requiring multiple resections to obtain an R0 resection, followed by adjuvant radiation to the primary. The...
Would you test for resistance mutations in this setting, using blood-based sample if no progression outside CNS?
Are there other adverse features aside from seminal vesicle invasion, positive margins, or extraprostatic extension that you consider?
Would you radiate? Surgery? Chemo? Follow with short interval scans?
How would size of adenopathy (e.g. <2cm vs larger) and time of recurrence (wi...
Patient did not previously receive para-aortic radiation. Considering RT vs RT + chemo vs chemo alone
Are there any effective non-pharm or pharm interventions?
Is chemoradiation a viable strategy in osteosarcoma?
Recurrence was 2cm and PET confirmed local. Excision with positive margins. Current plan for salvage whole pelvic RT and vaginal cuff brachytherapy +/...
Would you consider induction: TPF vs cis/gem or would you proceed with chemoradiation with cis/RT and consider adjuvant cis/5FU?
If so, would you recommend adjuvant chemotherapy and PCI after?
Would you change your radiation therapy treatment dose or volume if you needed to treat a chloroma? If a patient had a separate cancer (e.g. skin canc...
Eg T2N2 who required management of cardiac comorbidities leading to months-long delay but scans are still clear.
Recurrence picked up incidentally on CT. No germ line mutations, somatic tumor testing of node resulted negative.
PET confirmed isolated recurrence
Would you recommend radiation, systemic therapy alone, or chemoRT? What about if this recurrence occurred during or shortly after completion of adjuva...
The site of oligometastatic disease was to a supra-clavicular node and was biopsy proven.
Would you consider SBRT and continue osimertinib?
Is there a subset of patients you would avoid neoadjuvant CRT and operate first?
This patient had a Ki67 of 27%. However, the inclusion criteria for the NETTER-1 Trial was Ki67<20%. Would Lutathera be an option if labs are withi...
Presuming that imaging does not show distant metastatic disease, what would you offer? What about if the patient were PD-L1 negative?
What is your strategy to prevent and treat constipation in patients initiating or receiving opioids?
What non-pharmacological interventions do you recommend? Do you routinely prescribe prophylactic laxatives to patients initiating opioids? How do you ...
What clinicopathological features would need to be present for you to recommend adjuvant chemotherapy? Would you treat pT3 disease? Any specific histo...
Specifically, would you offer salvage radiation to a patient who underwent a prostatectomy with PLND and had a post-op PSA of 12 with pathology reveal...
Would you consider doing a pre-op RT prior to possible re-excision? If yes, what dose would you give? If the location is between L4-L5 spine.
In particular, for frail patients to avoid toxicity or for those that do not want chemotherapy
If so, do you allow a period of "washout" between immunotherapy and radiation?
Would you consider it for a patient who had bulky thoracic disease, with limited extrathoracic disease at diagnosis and achieved a CR after induction ...
Assuming all other factors are favorable (pT1-2, TME, negative margins).
Is there a threshold of when you would use chemo/radiation?
Is it essential to wait one week after loading dose of erbitux to start RT for head and neck cancer?
In the post-op setting, would you delay 1 week even if it took them out of the 6 weeks post-op window? Meaning the loading dose of erbitux was given d...
It is not clear from CREATE-X whether radiation was before or after capecitabine. Is there a preferred approach?
Conversely: In a patient with N2 EGFR+ NSCLC receiving radiation, would you still consider use of osimertinib?
In primary surgical resection, ENE on surgical path would be indication to add adjuvant chemoradiation. After progression through definitive chemoradi...
Is the short time to recurrence a reason to not consider definitive management with surgery/radiation?
Should systemic therapy be added if pursuing d...
How does dialysis affect PSA lab values?
How many cycles do you prefer before and after? How long do you tend to wait before starting radiation after initial chemo and after radiation to resu...
Specifically, for cT2N0M0 small cell bladder cancer without response to neoadjuvant cisplatin and etoposide on imaging, would you proceed with cystect...
If advanced stage do you follow same guidelines as Scc? Do you use same Cth regimen? Role of total laryngectomy ?
Would you offer refractory doses (40-50 Gy) to the RPnodes and send for splenectomy? Or would you offer refractory doses to both RP nodes and spleen?&...
Would you add abiraterone or enzalutamide?
I know many centers are exercising extra precautions in light of the new concerns with coronavirus. How are people explaining things to their patients...
Have the RAPID or CALGB 5064 studies changed your treatment approach?
Specifically, are there strategies you use to 1) empower patients to participate in decision-making and 2) reassure patients who may be skeptical?
If post-op with clear margins would you prefer adjuvant RT or close observation with surgery for optimal reduction of local recurrence? This particula...
Do you use specific tools or take into account certain factors when considering treatment options for older adults?
If so, what is your time threshold for when you'll start PCP prophylaxis--when you anticipate steroid courses greater than 1 week? 1 month? 3 months?&...
A recent NCBD analysis (Rusthoven et al, JCO 2016) suggests that the addition of prostate RT significantly improves survival compared to ADT alon...
Would you recommend re-excision or proceed to adjuvant therapy if the tissue margin is negative? Pathologist states that tumor foci at margin was only...
Does not technically meet high intermediate risk criteria.
If on pembrolizumab or nivolumab, when would you escalate to ipilimumab/nivolumab?
ASCO 2016 guidelines specified that SLNB was not recommended for T3/T4 N0 patients but uptodate allows it.
What is the risk of perforation / fistulization?
Would gross ENE or R1 resection trigger you to consider adding chemo? If so, do you use weekly cisplatin or cisplatin/etoposide?
For T2bN0 or T3N0 disease, you consider radiation alone, sequential radiation followed by chemotherapy, or concurrent chemoradiation?
Do you continue atezolizumab alone? Would you avoid anticoagulation?
After initiation of anti-TB treatment and 3 negative AFB smears, would you initiate concurrent chemoRT? Would you give sequential RT then chemo to giv...
In light of the SIRveNIB trial results and now IMbrave150, what is the role of intra-arterial therapy now?
Do you re-test patients who test positive for COVID-19 during or prior to starting cancer treatment?
There are mixed recommendations about re-testing vs simply waiting for a quarantine period prior to resuming therapy.
NCCN recommends either ISRT with rituximab/chemotherapy or ISRT alone in this scenario. What factors help your decision making?
Would you consider adjuvant chemotherapy, radiation therapy, hormone therapy, or surveillance?
This has become standard practice at our institution for patients with a good performance status, with whole brain radiotherapy given after the comple...
Which Radiation modality, if any, would be preferred?
Typical chemotherapy does not work for SFT. In which circumstance would you use VEGF ( Temozolo...
If you would elect for adjuvant therapy, which study helps guide your choice of regimen?
Are you employing more or less primary chemoRT v. surgery for some cancers? Are you dose de-escalating? What are issues radiation oncologists should b...
Would you consider it for a patient with good PS but with limited metastatic disease? What dose fractionation would you prefer?
The patient went straight to gastrectomy for clinical T1 gastric adenocarcinoma, but post-op was up-graded to T4 disease.
Both ARTIST and Inte...
Would you offer SBRT to both sites, SBRT to the primary and standard fractionation to the node due to proximity to the main bronchus/proximal lobar br...
Would it matter the site of recurrence (ie lung nodule vs bone lesion)?
After optimizing symptoms and reversible factors, and attempting cognitive-behavioral interventions and exercise, do you recommend pharmacologic agent...
This case involves an impressive ‘high volume’ vaginal recurrence and patient was not originally planned for adjuvant therapy. Concerned t...
How do you decide on other chemo regimen? (Dosing, frequency, carboplatin based, non-platinum based etc.)
Would you use Cetuximab?
Altered fractiona...
Presented with mass projecting into right/left anterior ethmoid complex
What do you do/say when a discussion of evidence-based information doesn't convince a patient that this is her best chance of cure? Some patients even...
Has anyone omitted post path fracture radiation of pelvis/long bone in favor of starting endocrine treatment first? Or would one omit RT and start a C...
Ie for patients who are inoperable due to comorbidities?
The upfront plan is to use a definitive radiation dose of 66 Gy. My reading supports the use of 5FU + cisplatin but another doctor is recommending FOL...
Would you consider this refractory disease and go on to salvage regimen and auto-SCT, or is there a role for definitive XRT to the site of residual di...
The recent NELSON trial evaluates screening in a slightly different population than the USPSTF/NLST criteria. Which will you follow?
>5cm. If so, what is your preferred regimen?
If neurologic symptoms are absent or controlled, does that affect your treatment decision?
MRI? Endoscopy? Physical exam?
Is there evidence for radiation therapy in this setting?
E.g. a patient with progression of their primary cancer but still is testing COVID19+ over a month after infection?
What is the added benefit of Chemo-RT vs RT alone?
How does your approach differ for patients with stage IIA versus IIB disease? Age?
If so, would you consider it with monotherapy only or also with combined checkpoint blockade?
I care deeply about clinical trials but have always struggled on how to approach this topic. I would really appreciate tips from those of you who have...
Is there data to support every 3 week dosage v. weekly?
What dose of radiation, what type of chemo, and what indications?
For a patient not on dialysis? Outside of single agent 5FU, all other standard chemotherapeutic options would be contraindicated for nephrotoxicity.&n...
Would you consider the addition of chemotherapy to proton beam therapy?
This has been a common practice in the community. Is there a benefit for certain patients?
At what age would you treat an early stage hodgkins lymphoma patient with ABVD + RT (adult treatment) vs OEPA x 2 or AV-PC x 3 (pediatric paradigm)?&n...
When using short course RT, the NCCN guidelines currently recommend short course RT followed by chemotherapy, followed by surgery. Many surgeons are h...
Guidelines do not provide strong guidance on who will benefit from temozolomide vs PCV or when to consider re-challenging with temozolomide.
How do you decide between WBRT, maintenance chemotherapy, or stem cell transplantation?
Do different modalities of imaging (PET vs MRI vs CT) help you to distinguish one etiology versus the others? What about other clinical characteristic...
Obviously, patient and caregiver preferences are paramount. But, what factors do you consider? Does expanded hospice (e.g., Medicare Care Choices) inf...
How do you prescribe a steroid taper? If it is grade 2, would you keep them on low dose prednisone while continuing? When do you feel comfortable re-c...
Aside from smoking cessation, what interventions have you found useful to manage patients with chronic symptomatic laryngeal edema? Steroids seem to b...
How are you modifying your current sarcoma-directed therapy in the setting of the COVID-19 pandemic?
For example, would you consider switching to an outpatient regimen in lieu of AIM for metastatic soft tissue sarcoma?
If so, what dose-fractionation regimen do you utilize? What are your target volumes?
Should staging and treatment decisions be made based on imaging alone?
Acknowledging that there is no time for good trials yet in this setting
How would you approach a patient who is receiving chemoRT but has confirmed COVID-19 with minor symptoms, as breaking treatment for 2 weeks quarantine...
Would your practice vary based on hormone receptor or Her2 status?
When a physical exam is important and telehealth is not a good option, should we be proactive and reschedule or should we continue to see them as sche...
Mitigating the spread of COVID-19 is of utmost priority now that containment measures have failed. Social distancing will help "flatten the curve" of ...
Is there specific workup you perform? Are there preventive measures? Once established, are there non-pharmacological and pharmacological treatments yo...
Assuming the patient is not a candidate for SRS
Do the potential late effects offset any benefit of mediastinal XRT in a young patient with bulky disease?
Any adjustments in terms of elective nodal coverage?
How would a much higher risk cancer affect decision making? How would you treat him?
Specifically with reference to rural settings where the logistics of early in the week delivery may be more challenging.
Do the results of the unplanned subset analysis of the PACIFIC trial showing no OS benefit in this population lean you away from consolidation?
Our medical oncology team wants to give a patient Vitamin B12 and Folate 1 week before chemo- do we need to push back the RT start date to start both ...
This question has come up most frequently with respect to the flu vaccine recently. Also, frequently this has been asked about the shingles vaccine an...
Would you recommend it for a mammographically occult primary or if the patient had dense breasts? What if a high risk patient decides not to hav...
Would your choice of concurrent chemotherapy be impacted by this histologic finding?
In patients who have a mixed response or progression and are poor candidates for other systemic agents, would you consider consolidating the chest? Wo...
i.e. doxorubicin, ifosfamide + RT. Do you worry about decreased locoregional control or increased toxicities with the use of G-CSF in combination with...
The German trial included patients with tumors up to 16cm from the anal verge, while the Swedish trial update found no local control benefit for tumor...
-The data on induction for adult H&N ca has been mixed (excluded NPX) but recent data suggest a benefit for adult NPX.
-Given that this is standa...
For instance, if the fluclicovine scan shows a few small avid nodes not only in the pelvis but extending to the paraaortic region, would you treat the...
Is there a "best" way to approach treatment of the viral infection i.e concurrently with therapy, prior to therapy, delayed or post therapy? Does this...
Would you suspect progressive disease v. radiation necrosis vs optic neuritis due to immunotherapy. Eyes were within radiation field 8 months ago.&nbs...
NCCN recommends annual CT surveillance indefinitely after year 5, but I’m curious how many physicians continue and for how long?
Would you alter your SBRT dose? How long would you hold the VEGF inhibitor before and after? Does the primary matter (e.g. NSCLC vs. colorectal)?
The NCCN seems to make its recommendation based on extrapolation from colon cancer, but those patients are not treated with pre-op chemoRT.
Specifically, how do you explain potential cognitive decline in a way that explains what changes they can expect in their daily lives?
Based on the RADICALS-RT trial presented at ESMO, can RT be omitted in post op prostate patients in favor of salvage RT? If not which group of patient...
Specifically concurrent ifosfamide? Induction AIM?
How long would you continue androgen deprivation after radiation?
What are the targets (tumor bed, positive margin, nodes etc.)?
Would PDL-1 status impact your decision?
Do you recommend or make any modifications in the PACIFIC regimen for patients > 75 years of age?
Should cystectomy remain standard of care?
(Recently debated in JAMA Oncology:
http://jamanetwork.com/journals/jamaoncology/article-abstract/2520055...
Some specific questions:
Would you recommend repeat biopsy to confirm residual disease?
How would your recommendations vary if the patient had pre...
I understand the perioperative trials are not based on tumor regression in cancer cells.
Do you offer consolidation chemotherapy prior to durvalumab in locally advanced, unresectable NSCLC?
In clinical practice, consolidation chemotherapy is sometimes used, though this was not implemented in the PACIFIC trial.
https://www.ncbi.nlm.nih.go...
Per the ALSYMPCA study, they excluded patients with > 3cm lymphadenopathy. Patient is currently on enzalutamide and leuprolide and refuses docetaxe...
For instance, in borderline cases for neoadjuvant therapy (e.g. T2N1 disease), should both be obtained to increase accuracy?
Would you give chemotherapy concurrently with radiation? Would you change your radiation dose?
CT or PET? If so, how often?
Does the STAMPEDE trial, showing a survival benefit with the addition of docetaxel to standard treatment, change the standard of care for high risk, n...
Would you offer definitive management with radiation and ADT? Or systemic therapy alone such as with ADT+abiraterone?
What are the major factors that impact your decision? If you opt for surgery, what factors impact your decision to offer RT preoperatively vs. postope...
Rate of pneumonitis was low in the PACIFIC trial but does it mirror the real world setting? We are seeing increased pneumonitis in our practice.
https://www.nejm.org/doi/full/10.1056/NEJMoa1813181
Is IO related pneumonitis in the radiation field or more diffuse?
Some ENTs advocate for a neck dissection as a way to avoid chemotherapy if there is a high chance there is no ECE. This is without removing the primar...
Would you follow an algorithm such as the one proposed by Hall et al?
How do you decide between intrathecal chemotherapy vs systemic therapy with HD-...
Would you proceed with induction chemotherapy (eg TPF or cis/gem) to downstage or neoadjuvant chemoRT? Would your approach be different if there is or...
Do you feel it is important to start durvalumab within 14 days of completing cCRT? What real life challenges do you face in doing so and wh...
Have you seen RAI or lenvatinib be efficacious for locally advanced disease — allowing for better surgical outcomes? Do you utilize EBRT?
Medical inoperability is clearly defined, anatomical resectability is also pretty much clear (invasion of trachea/carina/esophagus, etc). But what abo...
Would you treat to the GEJ regardless of whether the positive node was identified in the upper portion of station 8? Do surgeons routinely dissect to ...
Do you follow invasive or DCIS guidelines? Would you consider re-excision in a patient with multifocal microinvasive carcinoma of the breast arising i...
If so, how would you modify this regimen?
If you are using a standard 30/10 fractionation, is there a benefit to keeping chemo on board for radio-sensitization?
The EGFR subgroup appeared not have benefited as much as other patients in the publication. However, recently it was reported that the PACIFIC study m...
For the first treatment day (during combined chemo/XRT courses), is it ok to give XRT first then send the patient for chemo or should the chemo be giv...
The NCCN recommends either systemic therapy + brachytherapy or pelvic RT + brachy or brachy alone or observation. How do you decide among these option...
Is there a role for SBRT with or without the addition of systemic therapy?
What features would make you more likely to recommend radiation therapy with chemotherapy?
No other site of metastatic disease. It is unclear if this situation should be managed as two separate primaries or metastatic disease.
Do your recommendations differ if patients are pre or postmenopausal given the data?
There is no primary and no distant disease seen on restaging PET. RTOG 0236 shows significant regional failure rate. Some have reported salv...
Do you ever start radiation +/- 24-48 hrs from C1D1 for chemotherapy due to logistical barriers?
Do you prefer chemotherapy to start at beginning of ...
Which appetite stimulants are the most effective? How do you respond to patients who request medical marijuana?
Hormonal therapy would not be tamoxifen.
Since the randomized phase II data from Gomez et al presented at ASTRO 2018 showed a survival benefit, is there concern about randomizing patients to ...
Is concurrent chemotherapy necessary for these patients?
Does the lack of D2 dissection automatically necessitate adjuvant chemoradiation therapy (ie <5 LN obtained)? Would the presence of high risk facto...
Does papillary histology influence your decisions regarding surgery, chemo, radiation dose or nodal coverage?
For a patient with cT3-4N0 rectal cancer, does the dose of the previous RT affect your decision making (for example, 45 Gy to the pelvis with boo...
If there is no other evidence of metastatic disease, would you offer thoracic radiation? Either upfront with chemo or after initial system therapy if ...
Abstract LBA5_PR ‘Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCA): survival results from S...
Routinely? Only with oropharyngeal cancer etc.? Given that low expression of EGFR subset did better, do you believe there is a true benefit in cetuxim...
Is this recommended in a certain subset of patients (EGFR positive or 1 metastasis only)? Or should we await maturation of the MD Anderson/Colorado/On...
Or do you wait for platinum resistance?
If so how would you select patients (ie. PS, histology, PD-L1 expression level)?
For example, would a + vascular margin, extranodal extension of N1 disease, translobar disease, or high risk histologies (large cell neuroendocrine, s...
Would you repeat PET or is it adequate to change to CT surveillance? Although surveillance PET/CT is not recommended by NCCN guidelines, these are oft...
Would you use the same schedule as early stage NSCLC primary?
The current NCCN guidelines reserves radiation for patients who are not resectable after induction chemotherapy. Does it make sense to offer concurren...
Do you prefer carboplatin-paclitaxel-bevacizumab, carboplatin-pemetrexed-pembrolizumab, or chemotherapy alone?
Would this be any different for whole brain radiotherapy?
Would you consider repeating neoadjuvant chemo/RT? Does this, occurring in the context of Lynch Syndrome, change the treatment approach?
A recent phase III trial published in JCO describes the NVALT-11/DLCRG-02 study, evaluating PCI vs observation in patients with stage III NSCLC s/p co...
I have a patient who will be climbing to the base camp of Mount Everest. Does a climb to 15,000 feet increase her risk? Should she wear a compression ...
Or would you wait to start coincident with the start of cycle 2? If a shorter time from the start of any therapy to the end of radiation (SER) is sign...
Are these patients better candidates for preop chemotherapy alone?
Can SRS or whole brain radiotherapy be reserved for progression in these young, healthy patients?
In the context of the new staging systems and possible differences of HPV mediated vs smoking mediated oropharynx SCC, would you ever not recommend co...
By the definition this would be M1 disease, but would definitive treatment be appropriate? Is there clear data that a single pleural nodule has no cha...
Current NCCN guidelines seem to support a variety of approaches.
If the patient has large, bulky nodes would you consider starting after chemotherapy for cytoreduction? Or otherwise consider replanning mid-treatment...
How does it vary for patients with a history of hypertension, diabetes, CHF, and coronary artery disease?
When would you favor delivering local therapy (e.g. SBRT) prior to systemic therapy?
5FU/mitomycin C or 5FU/cisplatin? Is there any benefit of cisplatin in terms of skin toxicity?
Is there any data on safety of radiaiton with pertuzumab?
Would you treat this as a locally advanced breast cancer and offer surgery, radiation, and systemic therapy? Does your management change depending on ...
These patients have been largely excluded from these trials. What if the infection is well controlled?
Do you refer all patients who are felt to be at high risk to a genetic counselor for testing or are you comfortable performing a MyRisk panel in your ...
If you treat pre-chemotherapy volumes, is there a benefit to induction chemotherapy even in bulky disease. If so, how do you define disease that ...
Masuda et al. NEJM 2017
If so, how do you sequence it with adjuvant radiotherapy?
What factors influence your decision (R1 v. R2 resection? T stage?) If sequential, do you typically prefer radiation before or after chemotherapy?
Obviously the details matter a lot, but are there guiding tenets one should follow beyond expressing condolences to the family?
This is a recently described entity with poor prognosis, so even with a CR after RCHOPx6 cycles, is your bias to push for ISRT due to EBV being poor p...
This is in regards to the risk of secondary cancers after radiation therapy or cytotoxic chemotherapy (such as anthracyclines) in an immunosuppre...
Would you recommend radiation and/or systemic therapy? If you would irradiate, what would your fields/volumes look like?
For a lesion that appears radiographically consistent with a high grade glioma, would you treat empirically if there is hesitancy to perform a high ri...
If so, what regimen would you consider?
Or do you recommend treatment with systemic therapy alone, as this represents Stage IV disease?
How does this approach change with mediastinal lymph node involvement? What are the indications for definitive or adjuvant radiotherapy +/- chemothera...
The current treatment for bladder adenoCA is surgery. However in non-surgical candidates, RT is an option. Would you consider adding chemo ? Also woul...
If you recommend or use induction chemotherapy, what is your preferred chemotherapy regimen?
What is the best evidence for what dose to use? When would you give it in relation to the checkpoint inhibitors? Which metastatic sites do you choose ...
If a patient will receive a total of 4 cycles ABVD and has a CR by PET/CT after cycle 2, can RT be omitted to non-bulky sites to avoid toxicity?
If so, how do you manage counseling for someone with low health literacy?
When there is biopsy proven mediastinal disease, do you offer definitive chemoradiation and monitor, or do you try to prove the presence/absence ...
Would you offer definitive radiation/chemoradiation if he is refusing cystectomy?
The FDA recently approved neratinib based on data from the ExteNET trial; however, benefit appears modest and the risk of toxicity is not low.
Do you offer neoadjuvant RT with resection and node dissection vs. definitive radiation? How extensive does the nodal disease have to be for you...
In patients with new bone pain and without any evidence of bone metastases receiving GnRH agonists, how do you manage pain symptoms?
What dose and volumes would you use?
Are the results of the STAMPEDE trial presented at ASCO 2017 practice changing?
PET/CT/bone marrow biopsy negative for evidence of distant disease. Following 4 cycles of combination chemotherapy with no evidence of progressive dis...
Is there any role for a trageted agent with CNS penetration (such as second generation ALK inhibitors) after completion of postoperative brain radiati...
If not, what is your thyroid hormone withdrawal protocol? If so, would you still treat a patient with possibly metastatic disease?
Does your management differ if the hiccups are felt to be related to chemotherapy as opposed to the disease itself?
In a patient who already received 13 courses of radiation (with complete response), is there any other effective treatment?
In LAP07's second randomization (capecitabine+54 Gy vs maintenance gemcitabine +/- erlotinib), 60% of unresectable pancreatic cancer patients who did ...
To what extent do you worry about overlapping myelosuppression? Is there any advantage to overlapping therapy?
Is there a role for salvage LN dissection or salvage RT to the node? And is there a role for systemic therapy (ADT or chemotherapy) in addition? If yo...
Two retrospective studies from Stanford showed that patients who received ADT had an increased risk of dementia and Alzheimer's. Is this finding ...
If a patient developed locoregional recurrence after initial chemoradiation, would resection of known disease followed by observation be preferred?
Do you use a PSA threshold, PSA doubling time, or only evidence of metastatic disease to trigger ADT? For those without rapid doubling time, do you ev...
For instance with isolated progression at one metastatic site, with all other disease stable and clinically doing well.
How would the new data presented at ASCO GI 2021 from from Alliance A021501 influence your answer?
Is there a role for routine use of additional or alternative imaging modalities for these patients, such as tomosynthesis, MRI, or ultrasound? I...
Some medical oncologists tend to hold anticoagulation in patients who develop brain metastases for fear of causing intracranial hemorrhage. Is t...
Would your recommendations change if it was a partial vs complete radiographic response?
Would you add chemotherapy if there was gross residual disease, pN+ and/or ECE?
How long do you typically wait before starting consolidation chemotherapy, and do you routinely perform re-staging scans prior to consolidation?
Can the classic indications for post-hysterectomy radiation (eg. "Sedlis" and "Peter's" criteria) be applied? Does the histology change radiation dose...
In the setting of recent craniotomy and a plan for SRS to the surgical cavity, which systemic therapy would you choose and when would you start it?
The immediate response by patients in this situation seems almost universally to be, "But I'll starve to death!" Referencing literature about lack of ...
For a patient with a history of non-muscle invasive disease in the bladder, presenting with a prostatic urethra only recurrence, do you approach this ...
Radium-223 has an overall survival benefit and lower hematologic toxicity, but at a significantly increased cost. Does the cost-effectiveness fa...
This is rarely done, but recently came up in a tumor board discussion. Which chemotherapy would you consider using, and when?
Reference: https://www.ncbi.nlm.nih.gov/pubmed/23578724
In particular, would you offer memantine to those with WHO II or III gliomas and a good performance status but larger treatment volume?
Is MRI being considered the primary mode of imaging in multidisciplinary tumor boards, especially in light of the results of the MERCURY trial (JCO 20...
Specifically, is there still a role for dd RCHOP followed by ICE, or do you recommend DA-R-EPOCH for all patients?
Does the site of palliative radiation therapy matter (i.e. femur, abdomen, pelvis vs base of skull)? How long should you wait to give palliative ...
The Phase III J-ALEX study and two phase II studies seem to suggest favorable intracranial response rates for alectinib.
What about patients who are still on steroids for radiation pneumonitis?
Would taking the drug at a specific time point prior to their radiation appointment time to maximize blood levels of the drug be clinically beneficial...
What do you consider when making this decision (concurrent chemotherapy, amount of bone marrow in field, whether patient is already on antibiotics, et...
Does your recommendation change depending on the agents they received?
Do other factors (i.e. Gleason score, pretreatment PSA, or pT stage) affect your decision?
If so, when? Although anemia is associated with worse local control in HN cancer, I don't know of any data that shows that blood transfusions can help...
Is there data supporting the idea that chemotherapy must be onboard prior to delivering radiation for maximal radiosensitization (particularly for hea...
Given recent advancements in the understanding of biological differences in prostate cancer patients of African vs. other ancestry, does your manageme...
Do you have a preference for specific steroids? Some practices may switch to prednisone during this time.
Patients with gliomas are often on d...
Are there specific subsets for whom these results should change management?
In situations where there is a significant risk of either local or nodal persistence/recurrence post prostatectomy with a rising PSA, or nodal involve...
In a patient who recently completed NAC, TM/LND and PMRT for a hormone positive locally advanced breast cancer and is then found to have a contralater...
Assuming the patient is a candidate for either of these treatments?
We have a great palliative care clinic and I like to refer many patients with metastatic disease, even if I feel that they will live a year or two lon...
Is there any consensus regarding the optimal RT dose, fractionation, and timing to the best abscopal response? What is the optimal metastatic site to ...
If the systemic agent is going to be held, how many days prior to starting radiation therapy should the agent be held and when can it be restarted aft...
If a patient had a recurrence that was pathologically proven despite negative idodine scans, what imaging scans would you follow up with for surveilla...
In a patient with node positive disease, treated definitively with radiation, should continuous or intermittent ADT be administered? If a patien...
As it is suggested for larger tumors treated with surgery, based on post hoc CALGB analysis?
The NCCN guidelines discourage the use of PET/CT surveillence but the recent analysis of RTOG 0235 found post-CRT PET uptake to be associated with wor...
Based on the European data published in the Lancet (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2961085-0/abstract), are you s...
What dose do you recommend?
I know that some would argue that healthy patients with an excellent performance status may not need an early palliative care referral, but wouldn't i...
In a patient with an R0 resection, would you routinely recommend postop chemoradiation, since these patients were included in the MacDo...
Our Radiation Safety officer reports a higher radiation dose to the patient from the two scans vs the PET.
Do you favor a short palliative regimen, or a full course definitive treatment to 64.8Gy? How does your management change if the patient has a good pe...
What factors should be considered with offering SBRT to oligometastatic bone disease in prostate cancer patients? Should this been done off of a proto...
I am aware that chemotherapy can obviate the need for RT in patients with SVC syndrome, but I'm not sure if this can be extrapolated to spinal cord co...
If so, what would you include in the target and what dose?
Assuming a patient who could tolerate either, which is preferred? Does this depend on the choice for concurrent chemotherapy (5FU+mitomycin vs ci...
If a patient with stage I, low grade follicular lymphoma achieves a complete response after rituxan and treanda is there any role for consolidative ra...
Are there any open clinical trials testing this?
Our ENT surgeons often tell patients with evidence of matted nodes on imaging that their swallowing function will be much worse after 70Gy as compared...
Do you really feel the failure was because people crossed over to bev at progression, or is it simply that bev does not affect overall survival?
My patient’s family has asked that I don’t tell her that she has metastatic cancer because it will devastate her. I am planning on palliat...
I've read about patients who were treated with concurrent bevacizumab-RT who developed lethal tracheoesophageal fistulas. How long would you have to w...
Definitive chemoradiation vs. surgery followed by adjuvant radiation/chemoradiation?
Even though we do not have the best data on the use of induction chemotherapy, what are current practices?
Is your practice different between HPV+ an...
Is there a consensus on the MAGIC v. MacDonald debate?
Papers discussed in this category
Gynecol Oncol, 2019 Aug 16
JAMA,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-03-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-09-01
The Lancet. Oncology, 2013-03
Cancer, 2004-03-15
Mayo Clinic proceedings, 2012-03
Oral oncology, 2016-09
N Engl J Med, 2006 Jul 6
The New England journal of medicine, 2001-09-06
BMC Cancer, 2015-07-21
International journal of radiation oncology, biology, physics, 2013-09-01
Proceedings of the National Academy of Sciences of the United States of America, 2011-03-15
JAMA Netw Open, 2021 Apr 01
Cancer, 2002-06-01
N Engl J Med, 2007 Aug 16
J Clin Oncol, 1999 Jul
Lancet, 2015 Jan 3
International journal of radiation oncology, biology, physics, 2011-11-01
Int. J. Radiat. Oncol. Biol. Phys., 2006-09-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2017-12
Lancet Oncol., 2017-05-01
The New England journal of medicine, 1999-08-12
BMC Cancer, 2015-08-15
Journal of cancer research and therapeutics, 2012
International journal of radiation oncology, biology, physics, 2012-05-01
Neurosurgery, 2013-10
Practical radiation oncology, 2015
J. Neurosurg., 2005-01-01
J Korean Neurosurg Soc, 2011-08-01
Radiat Oncol, 2014-07-08
BMC Cancer, 2015-03-04
Acta Neurochir (Wien), 2013-01-01
The Lancet. Oncology, 2009-11
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007-04-01
J Clin Oncol, 2011 Jan 10
JAMA, 2016-07-26
Radiation oncology (London, England), 2014-09-30
Cancer, 2016-06-15
J. Clin. Oncol., 2018 May 22
Lung cancer (Amsterdam, Netherlands), 2018-06
The New England journal of medicine, 2018-08-23
The New England journal of medicine, 2018-12-06
International journal of radiation oncology, biology, physics, 2019-04-01
Lancet, 2019 Oct 04
JAMA oncology, 2019-06-01
International journal of radiation oncology, biology, physics, 2019-04-01
International journal of radiation oncology, biology, physics, 2019-04-01
Neurosurgery, 2019 Oct 10
JAMA Oncol, 2020 Jun 4
J Clin Oncol, 2020 Aug 10
Lung Cancer, 2014 Aug 02
N Engl J Med,
Lancet Oncol, 2020 Apr 03
Int J Radiat Oncol Biol Phys,
JAMA,
J Neurosurg,
Cancer,
International journal of radiation oncology, biology, physics, 2013-03-15
International journal of radiation oncology, biology, physics, 2011-05-01
International journal of radiation oncology, biology, physics, 2011-11-01
J. Clin. Oncol., 2014-04-10
J. Clin. Oncol., 2013-11-10
Lancet Oncol., 2012-01-01
The New England journal of medicine, 2015-02-19
The New England journal of medicine, 2010-08-19
The New England journal of medicine, 2013-03-28
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-05-01
Oncology (Williston Park, N.Y.), 2012-12
N. Engl. J. Med., 2010-08-12
The New England journal of medicine, 2013-04-11
Cancer, 2007-11-15
Cancer, 2015-04-01
JAMA, 2012 Jul 11
JAMA, 2008-03-05
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-08-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-20
International journal of radiation oncology, biology, physics, 2011-09-01
American journal of clinical oncology, 2011-02
International journal of radiation oncology, biology, physics, 2013-12-01
JAMA, 2007 Jan 17
Cancer, 1987 Jun 15
Ann Surg, 2007 Nov
Radiother Oncol, 2006 Oct
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-07-01
International journal of radiation oncology, biology, physics, 2012-06-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015-01
Lancet, 1998 Jul 25
Int. J. Radiat. Oncol. Biol. Phys., 1999-08-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-03-10
The Lancet. Oncology, 2010-01
Oral oncology, 2014-05
Head & neck, 2015-03
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-04-20
International journal of radiation oncology, biology, physics, 2018-03-15
International journal of radiation oncology, biology, physics, 2016-06-01
Int. J. Radiat. Oncol. Biol. Phys.,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-01-01
Cancer, 2010-10-01
Head & neck, 2016-04
Cancer, 1990-11-01
Ann. Oncol., 2010 Apr 28
J Clin Oncol, 2017 Dec 8
Radiat Oncol, 2015 May 27
International journal of radiation oncology, biology, physics, 2016-06-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-04-01
The New England journal of medicine, 2016-11-10
The New England journal of medicine, 2018-01-11
N. Engl. J. Med.,
Journal of the National Comprehensive Cancer Network : JNCCN, 2018-10
JAMA Netw Open, 2019 Aug 2
Pract Radiat Oncol, 2020 May - Jun
J Thorac Oncol, 2021 Feb 02
J Clin Oncol, 2021 Jan 27
Int J Radiat Oncol Biol Phys, 2020 Nov 18
J Clin Oncol, 2021 Aug 11
Eur Urol, 2015 Jul 16
BJU Int, 2009 Feb
European urology, 2014-06
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-07-01
The New England journal of medicine, 2013-07-18
International journal of radiation oncology, biology, physics, 2015-11-01
The Lancet. Oncology, 2015-02
Eur. J. Nucl. Med. Mol. Imaging, 2014-06-01
Cancer, 2004-08-15
Br. J. Haematol., 2003-11-01
Br. J. Haematol., 1998-08-01
Cancer, 1990-11-15
Radiother Oncol, 1990-01-01
Oral oncology, 2018-03
J. Clin. Oncol., 2018 Mar 14
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-11-01
Semin Radiat Oncol, 2015 Oct
N. Engl. J. Med.,
Lancet Oncol., 2015 Dec 16
Lancet,
Lancet, 2016 Mar 19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-05-10
JAMA oncology, 2018-06-14
J. Clin. Oncol., 2019 Oct 08
The New England journal of medicine, 1985-06-06
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-11-01
J Can Assoc Radiol, 1981-09-01
J. Clin. Oncol., 1985-03-01
J. Natl. Cancer Inst., 1988-07-20
Ann. Oncol., 2008-09-01
Radiother Oncol, 2011-01-01
Acta Oncol, 2011-10-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-01-20
Gastrointestinal cancer research : GCR, 2007-03
Practical radiation oncology, 2013
International journal of radiation oncology, biology, physics, 2017-02-01
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019-02
Technol Cancer Res Treat,
Am J Clin Oncol,
N. Engl. J. Med., 1999-01-28
Lancet Oncol., 2017 Jun 20
The oncologist, 2016-02
Clinical lung cancer, 2017-11
Anticancer Drugs, 2016-06-01
Practical radiation oncology, 2011
N Engl J Med, 2014 Mar 27
N Engl J Med, 2013 Jun 20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-12-01
J. Nucl. Med., 2015 Jun 25
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-04-01
Lancet Oncol., 2010-02-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-03-20
The Journal of urology, 2005-08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-12-10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-11-10
The Journal of urology, 1999-07
Annals of oncology : official journal of the European Society for Medical Oncology, 2009-03
The New England journal of medicine, 2018-05-03
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002-08-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-06-20
The Journal of urology, 2002-09
Clinical cancer research : an official journal of the American Association for Cancer Research, 2009-01-15
Nature, 2005-12-08
The New England journal of medicine, 2001-12-06
Lancet, 2001-09-22
Breast Cancer Res. Treat., 2010-02-01
The Journal of urology, 1982-06
Cancer research, 2000-04-15
J. Clin. Oncol., 2009-04-01
Oncol. Rep., 2015-12-01
Nat Commun, 2015-04-01
PLoS ONE, 2016-01-01
J. Urol., 2002-04-01
Lancet Oncol., 2015 Sep 09
European urology, 2018-02
Lancet, 2018 Oct 18
The breast journal, 1999-01
Annals of surgical oncology, 2010-10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01
Br. J. Cancer, 2015 Jun 30
Head & neck, 2006-04
Journal of neuro-oncology, 2014-03
Brain : a journal of neurology, 2017-03-01
Radiat. Res.,
Lipids Health Dis, 2017 Jun 02
Blood, 2015-07-23
The Lancet. Oncology, 2010-01
The New England journal of medicine, 2004-12-30
The New England journal of medicine, 2014-02-20
The New England journal of medicine, 2014-02-20
Neuro-oncology, 2016-09
Onco Targets Ther, 2017 Jan 18
The Lancet. Oncology, 2006-06
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-06-20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-02-20
JAMA oncology, 2016-04
JAMA oncology, 2017-01-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-06-10
International journal of radiation oncology, biology, physics, 2006-02-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-03-15
Journal of the National Cancer Institute, 2001-12-05
International journal of radiation oncology, biology, physics, 2000-09-01
Clin Lung Cancer, 2018 Nov
Neuro-oncology, 2013-10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-12-10
Lancet Oncol., 2013-05-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005-09-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007-05-01
Medical and pediatric oncology, 1990
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986-01
N Engl J Med, 2017 Nov 16
JAMA otolaryngology-- head & neck surgery, 2016-11-01
Canadian Agency for Drugs and Technologies in Health, 2016-10-31
The New England journal of medicine, 2019-06-13
Lancet Oncol., 2019 Jul 22
Gynecol Oncol, 2019 Sep
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01
J. Clin. Oncol., 2020 Feb 14
Neuro Oncol,
J Clin Oncol, 2021 Aug 11
International journal of radiation oncology, biology, physics, 2011-09-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-01-01
Cancer, 2013-11-01
Journal of geriatric oncology, 2015-03
International journal of radiation oncology, biology, physics, 2013-07-15
Advances in radiation oncology, 2017
The Lancet. Oncology, 2009-05
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017-02
Cancer, 2010 Aug 27
J Clin Oncol, 2008 Dec 01
Dis. Colon Rectum, 2014-04-01
Clin Oncol (R Coll Radiol), 2017-04-01
Prostate cancer and prostatic diseases, 2014-09
Gynecologic oncology, 2004-04
American journal of obstetrics and gynecology, 2010-10
Obstetrics and gynecology, 1988-01
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014-11
Gynecologic oncology, 2015-06
Can Fam Physician,
Journal of the National Comprehensive Cancer Network : JNCCN, 2014-04
J. Clin. Oncol., 2018-06-10
Pain practice : the official journal of World Institute of Pain, 2017-11
Med Phys, 2013-08-01
Int. J. Radiat. Oncol. Biol. Phys., 2009-01-01
The British journal of surgery, 2002-11
European urology, 2012-04
European urology, 2014-07
N. Engl. J. Med., 2012-04-19
J. Urol., 2007-09-01
J. Clin. Oncol., 2006-05-20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-07-10
The New England journal of medicine, 2015-08-20
N. Engl. J. Med., 2012-05-03
N. Engl. J. Med., 2012-05-03
Lancet, 2017-09-09
Journal of the National Cancer Institute, 2006-12-20
Medicine and science in sports and exercise, 2010-07
J Clin Oncol, 2016 Feb 20
Curr Breast Cancer Rep, 2016-01-01
Crit Rev Food Sci Nutr, 2018 Apr 19
JAMA, 2018-02-20
JAMA Oncol,
Cancer, 2010-05-01
N. Engl. J. Med., 2017-07-27
JAMA, 2013-10-09
JAMA, 2011-02-09
Lancet Oncol., 2013-04-01
Lancet Oncol., 2014-11-01
Breast, 2017-02-01
J. Clin. Oncol., 2015-01-20
International journal of radiation oncology, biology, physics, 2016-06-01
Oncology, 2013-01-01
PLoS ONE, 2015-01-01
Cancer, 2004-05-15
J Clin Oncol, 1998 Nov
International journal of radiation oncology, biology, physics, 2015-04-01
Int. J. Radiat. Oncol. Biol. Phys., 2016-11-01
Cancer medicine, 2016-12
Urology, 1999-06
Biomed Res Int, 2014 Feb 06
N. Engl. J. Med., 2015-04-23
Leuk. Lymphoma, 2007-09-01
The New England journal of medicine, 2015-10-22
Lancet (London, England), 2017-01-21
JAMA Oncol, 2016 Mar
Clin Oncol (R Coll Radiol), 2016-12-01
The New England journal of medicine, 2009-05-14
Ann. Oncol., 2009-02-01
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015-10-01
J. Clin. Oncol., 2011 Nov 21
N. Engl. J. Med., 2012-05-31
J. Clin. Oncol., 2016-08-10
Lancet Oncol., 2014-07-01
Ann. Oncol., 2014-07-01
J. Clin. Oncol., 2015-10-01
Cancer journal (Sudbury, Mass.), 2017
Radiat Oncol, 2014 May 29
Br. J. Cancer, 2014 Aug 28
J Gastrointest Cancer,
Radiographics : a review publication of the Radiological Society of North America, Inc, 2014-10
JCO Precision Oncology, 2017 Sep 29
Nature, 2017-04-26
Cancer discovery, 2017-12
The Lancet. Oncology, 2016-11
The New England journal of medicine, 2018-05-31
American journal of hematology, 2016-05
J Thorac Oncol, 2016 Oct 07
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-04-01
J. Natl. Cancer Inst.,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017-10
J. Clin. Oncol.,
N. Engl. J. Med., 2017-07-13
Cancer, 2018-04-15
Proc Natl Acad Sci U S A, 2015 Aug 3
Journal of the National Cancer Institute, 2018-01-01
Pediatrics, 2014-04
Vaccine, 2014 Dec 08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-09-01
Thorac Cardiovasc Surg, 2015 Dec 15
Gynecologic oncology, 2014-11
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-04-20
Cancer,
Head Neck, 2019 Feb 01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002-03-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-03-20
J Clin Oncol, 2007 Apr 1
J Clin Oncol, 2005 Apr 1
J. Clin. Oncol.,
Breast Cancer, 2012 Apr 25
Annals of surgical oncology, 2018-10
J Clin Oncol, 2022 Jan 07
JAMA oncology, 2019-06-01
Lancet Oncol, 2021 Jun 11
The New England journal of medicine, 2018-12-13
Radiat Oncol, 2015 Apr 26
International journal of radiation oncology, biology, physics, 2014-03-01
Breast cancer research and treatment, 2013-11
Annals of surgery, 2016-02
Breast cancer research and treatment, 2013-08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-03-01
The Lancet. Oncology, 2016-09
Clinical breast cancer, 2018-02
Breast,
N. Engl. J. Med., 2018 Jun 03
J Gastrointest Cancer,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-12-10
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014-04
Surgery,
The Annals of thoracic surgery, 2015-12
The Journal of thoracic and cardiovascular surgery, 2016-05
The Lancet. Oncology, 2012-07
Annu. Rev. Med., 2015 Aug 28
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-06-20
Lancet,
Lancet Oncol, 2019 Feb 19
Lancet Oncol, 2019 Dec 02
Lancet Oncol, 2017 Oct 13
JNCI Cancer Spectr, 2021 May 28
Cancer research, 2008-10-01
N. Engl. J. Med.,
J. Clin. Oncol.,
NPJ breast cancer, 2016
Practical radiation oncology, 2018
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-09-01
Lancet Oncol., 2015-09-01
The New England journal of medicine, 2002-10-17
Ann. Surg., 2007-11-01
N Engl J Med, 2021-04-01
J Clin Oncol, 2021 Apr 23
Lancet,
BMC Cancer, 2016 Jul 19
Oral Oncol., 2013 Nov 15
Cancer, 2009-07-15
Cancer, 2011-10-01
Hematol Oncol Clin North Am, 2019 Oct 28
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-06-10
Lancet Oncol, 2017 Jun
Lancet (London, England), 2017-10-28
The New England journal of medicine, 2016-12-01
The New England journal of medicine, 2012-04-12
The Lancet. Oncology, 2017-09
American journal of clinical oncology, 1997-06
The Annals of thoracic surgery, 2015-02
Thorac Cardiovasc Surg,
The Lancet. Oncology, 2017-07
International journal of radiation oncology, biology, physics, 2017-06-01
JAMA oncology, 2018-01-11
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-05-10
Int. J. Radiat. Oncol. Biol. Phys., 2012 Jun 05
Int. J. Cancer, 2016 Jun 30
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-02-20
The British journal of radiology, 2017-08
J. Clin. Oncol., 2013 Nov 25
Advances in radiation oncology, 2018
BMJ, 2006 Sep 19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-04-10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-01
Arch Surg,
Int. J. Radiat. Oncol. Biol. Phys., 2008-11-01
JAMA Oncol,
Lancet Oncol, 2021 Dec 15
The New England journal of medicine, 2019-02-14
Int. J. Radiat. Oncol. Biol. Phys.,
Gynecologic oncology, 2018-10
International journal of radiation oncology, biology, physics, 1994-06-15
International journal of radiation oncology, biology, physics, 2010-12-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010-06
JAMA oncology, 2019-05-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-11-01
International journal of radiation oncology, biology, physics, 2015-07-01
Tumori, 2018 May 08
Advances in radiation oncology, 2017
Lancet (London, England), 2009-08-01
Int J Radiat Oncol Biol Phys,
J. Clin. Oncol., 2015 Nov 02
Radiographics : a review publication of the Radiological Society of North America, Inc, 2004
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-03
The New England journal of medicine, 2015-07-16
International journal of radiation oncology, biology, physics, 2015-09-01
J. Clin. Oncol., 2020 Feb 27
Future Oncol, 2019 Apr 25
Ann. Surg.,
Journal of Cancer, 2017
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999-09
Future Oncol, 2018 May 09
Lancet Oncol., 2018 Apr 09
Lancet, 2019 Apr 11
Ann. Surg. Oncol., 2017 Mar 23
The Lancet. Oncology, 2019-03
Cancer, 2010-10-01
European journal of cancer (Oxford, England : 1990), 2013-03
American journal of clinical oncology, 2019-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2017-10
J Thorac Oncol, 2020 Sep 08
Lung Cancer, 2017 Jun
Radiother Oncol, 2011 Jun 12
Annals of oncology : official journal of the European Society for Medical Oncology, 2011-02
Lancet Oncol., 2014 Feb 18
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019-02
J Thorac Oncol, 2019 Feb 16
Radiation oncology (London, England), 2014-09-19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-06-01
International journal of radiation oncology, biology, physics, 2018-08-01
Int. J. Radiat. Oncol. Biol. Phys., 2016 Jul 15
Eur. Respir. J., 2018 Jan 04
Practical radiation oncology, 2018
JAMA Oncol, 2019 Jul 11
The New England journal of medicine, 2011-08-04
International journal of radiation oncology, biology, physics, 2017-05-01
The Lancet. Oncology, 2017-08
Neurology, 1989-06
Radiother Oncol, 2020 Jan
The Lancet. Oncology, 2016-07
Int. J. Radiat. Oncol. Biol. Phys., 2019 Aug 31
Lung Cancer, 2019 Jan 15
JAMA oncology, 2017-06-01
Neuro-oncology, 2019-02-23
BJU international, 2012-10
Cancer, 2011-09-01
Cancer treatment reviews, 2017-02
Strahlenther Onkol, 2019 Feb 08
Radiother Oncol, 2018 Jul 09
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-01-10
Clinical lung cancer, 2017-07
Int. J. Radiat. Oncol. Biol. Phys., 2020 Feb 07
Cureus, 2019 Jun 22
Lung Cancer, 2009 Jan 24
Radiat Oncol, 2016 Dec 03
Cancer treatment reviews, 2017-02
N. Engl. J. Med.,
Radiother Oncol, 2015 Aug 04
J. Clin. Oncol., 2019 Aug 29
Eur. Urol., 2018 Jul 03
Lancet, 2019 Apr 11
J. Clin. Oncol., 2017 Dec 14
Eur. Urol., 2019 Jul 19
J. Hepatol., 2019 Apr 06
J. Clin. Oncol., 2019 Sep 25
European urology focus, 2019-11
J Pharm Sci,
J. Clin. Oncol.,
Lancet, 2008 Dec 16
Lancet, 2011-12-17
N. Engl. J. Med., 2020 Jan 29
Int. J. Cancer, 2017 Jun 08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-01-20
J. Clin. Oncol., 2012-06-01
Lancet (London, England), 2007-12-15
Annals of surgery, 1999-07
Journal of the National Cancer Institute, 2000-03-01
Diseases of the colon and rectum, 2009-04
Radiother Oncol, 2012 Nov 28
J Gastrointest Oncol,
Radiat Oncol J, 2019 Jun 30
Radiat Oncol, 2019 Jan 16
Radiat Oncol, 2014 Jul 22
Radiat Oncol, 2016 Sep 05
The New England journal of medicine, 1994-08-25
N. Engl. J. Med.,
N. Engl. J. Med., 2019 Dec 11
Biotechnol. Prog., 2015 Mar 04
PLoS ONE, 2008 Jul 09
Public Health Rep,
Cochrane Database Syst Rev, 2011 Jul 06
BMJ (Clinical research ed.), 2010-03-02
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-01-01
Br. J. Cancer, 2013 Feb 05
Int J Radiat Oncol Biol Phys, 2010 Aug 21
JAMA Netw Open, 2019 Jul 03
Urology, 1995-12
J Urol,
Int. J. Radiat. Oncol. Biol. Phys.,
Lancet Oncol., 2020 Feb 14
J. Clin. Oncol., 2019 Sep 10
International journal of radiation oncology, biology, physics, 2005-07-15
International journal of radiation oncology, biology, physics, 2007-02-01
Annals of surgical oncology, 2015-12
International journal of radiation oncology, biology, physics, 1993-12-01
International journal of radiation oncology, biology, physics, 2017-12-01
Clin Oncol (R Coll Radiol), 2017 Dec 07
J Contemp Brachytherapy, 2019 Feb 28
Blood, 2019-05-16
Blood,
Eur J Gastroenterol Hepatol,
The Lancet. Oncology, 2015-08
Radiother Oncol, 2020 Mar 30
Ann. Surg., 2020 Mar 20
Lancet Oncol., 2017-03-01
Adv Radiat Oncol, 2020 Apr 22
Lancet (London, England), 2004-05-22
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-01-01
J. Clin. Oncol., 2019 Sep 25
Clin Oncol (R Coll Radiol),
Lancet Oncol., 2018 Mar 27
Cochrane Database Syst Rev, 2012 Apr 18
Cancer, 2016 Jun 10
International journal of radiation oncology, biology, physics, 2017-11-15
International journal of radiation oncology, biology, physics, 1997-03-01
Neurosurgery, 2020 Apr 21
J. Clin. Oncol., 2011 Mar 28
BMC Cancer, 2017 Apr 28
Ann. Oncol., 2019 Jun 13
J. Clin. Oncol., 2019 May 31
International journal of radiation oncology, biology, physics, 2012-11-01
Lancet Oncol., 2008 Jan 15
International journal of radiation oncology, biology, physics, 2016-03-15
Cancer medicine, 2019-05
American journal of clinical oncology, 2019-03
Lancet Gastroenterol Hepatol, 2017-07-01
Advances in radiation oncology, 2019
Lancet Oncol, 2020 Dec 07
Ann Oncol,
Lancet Oncol, 2021 Apr 13
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-12-01
The Lancet. Oncology, 2017-09
J Natl Compr Canc Netw,
Future Oncol, 2016 Aug 23
Radiother Oncol, 2009 May 14
The New England journal of medicine, 2006-02-09
Lancet (London, England), 2019-01-05
J. Natl. Cancer Inst.,
Journal of the National Cancer Institute, 2013-08-21
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010-02
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-07-20
Lancet Oncol., 2018 Feb 12
Leukemia & lymphoma, 2017-12
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-01-01
Int. J. Radiat. Oncol. Biol. Phys., 2012 Jul 24
Lancet Oncol., 2017 May 09
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007-01-20
N Engl J Med, 2020 May 14
Liver Cancer, 2019 Sep 18
Journal of the National Cancer Institute, 2011-10-05
BMC Cancer, 2018 Oct 12
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-12-10
Ann. Oncol.,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005-02-01
JAMA Oncol,
Urology, 2001-08
BMC Cancer, 2014 Sep 15
JAMA Oncol,
The Lancet. Oncology, 2010-10
JAMA, 2017-09-12
Int. J. Radiat. Oncol. Biol. Phys., 2019 May 11
The American surgeon, 2001-06
J Clin Oncol, 2014 Mar 24
J Natl Cancer Inst,
Ann Surg Oncol,
Clin Oncol (R Coll Radiol), 2017 Nov 16
Lancet, 2010-03-06
Lancet,
Gynecol Oncol Rep, 2020 Jan 30
World J Surg Oncol, 2017 Jan 10
Blood, 2018 Sep 6
J Clin Oncol, 2017 Mar 14
The New England journal of medicine, 2017-02-02
Lancet Oncol., 2016-06-01
JAMA Oncol, 2020 Mar 26
Lancet, 2020 Sep 28
Lancet Oncol,
Lancet Oncol,
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014-06
Radiother Oncol, 2020 Jul 31
N Engl J Med, 2020 Sep 19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998-01
Annals of surgery, 1982-09
Laryngoscope, 2014 Jul
Ann. Surg. Oncol., 2017 May 30
N Engl J Med,
The New England journal of medicine, 2017-07-27
JAMA Oncol, 2021 Feb 18
Endocr Relat Cancer,
J Nucl Med, 2018 Aug 16
Eur J Nucl Med Mol Imaging, 2017 Sep 12
Clinical genitourinary cancer, 2017-06
The Journal of urology, 2014-02
Annals of oncology : official journal of the European Society for Medical Oncology, 2014-12
J. Clin. Oncol., 2020 Jun 12
International journal of radiation oncology, biology, physics, 2018-09-01
Seminars in radiation oncology, 1993-01
Radiother Oncol,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-05-15
Cancer,
J Clin Oncol, 2016 Dec 28
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017-02-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-11-01
Radiother Oncol, 2020 Apr 01
The Lancet. Oncology, 2012-02
International journal of radiation oncology, biology, physics, 2016-11-01
Cancer, 2018-07-15
International journal of radiation oncology, biology, physics, 2018-10-01
J. Clin. Oncol., 2006-03-01
The New England journal of medicine, 1992-12-03
Ann Oncol,
International journal of radiation oncology, biology, physics, 2011-01-01
Lancet (London, England), 2009-03-07
International journal of radiation oncology, biology, physics, 1989-02
Int J Radiat Oncol Biol Phys,
The New England journal of medicine, 2007-10-25
N. Engl. J. Med., 2019 May 31
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998-04
N Engl J Med,
Urology, 2000-11-01
Abdom Radiol (NY), 2019 Aug 29
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000-04
Gynecologic oncology, 1998-08
Int. J. Radiat. Oncol. Biol. Phys., 2011 Jun 15
Cancer, 2004-12-01
EMBO Mol Med, 2020 Apr 29
J Oncol, 2020 Jun 24
Oncologist, 2018 Dec 12
Ann Oncol, 2020 Nov 20
JAMA, 2010-03-17
International journal of radiation oncology, biology, physics, 2015-06-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-05-20
Chest, 2003-11
Lancet, 2021 May 07
N. Engl. J. Med., 2016-10-13
J Urol, 2020 Apr 13
Eur J Nucl Med Mol Imaging, 2020 Aug 12
J Urol,
N Engl J Med,
Lancet Oncol, 2021 Mar 12
Gynecologic oncology, 2019-06
Gynecol Oncol, 2021 Mar 05
Hepatology (Baltimore, Md.), 2018-08
Radiology, 2018-06
Hepatology, 2021 Mar 19
J Clin Oncol, 2021 Jun 02
Annals of oncology : official journal of the European Society for Medical Oncology, 2013-11
Int J Radiat Oncol Biol Phys, 2015 Jan 30
Lancet Oncol., 2007-09-01
J Nucl Med, 2011 Jul 15
BMC Cancer, 2016 May 18
Eur J Cancer, 2021 Apr 29
N. Engl. J. Med., 2009-06-11
Lancet, 2021 Dec 23
Lancet Oncol, 2010 Oct 07
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-04-10
Prostate Cancer Prostatic Dis, 2020 May 13
The Lancet. Oncology, 2018-11
Clin Sarcoma Res, 2013 Dec 18
Int J Radiat Oncol Biol Phys, 2020 Apr 11
Practical radiation oncology, 2015
Acta Neurochir (Wien), 2019 Jan 29
Cancer, 2020 May 19
Bladder Cancer, 2020 Mar 28
Nature genetics, 2016-04
Human pathology, 2013-04
Urol Oncol, 2014 Jul 30
Br J Cancer, 2021 Jan 21
N Engl J Med,
The New England journal of medicine, 2018-04-12
The New England journal of medicine, 2018-06-28
The New England journal of medicine, 2019-03-28
Clin Cancer Res, 2019 Sep 11
Strahlenther Onkol, 2017 Jun 01
Lancet Oncol, 2019 Oct 16
JAMA Oncol,
Int J Radiat Oncol Biol Phys, 2019 Dec 1
Pract Radiat Oncol, 2020 Oct 21
International journal of radiation oncology, biology, physics, 1988-02
International journal of radiation oncology, biology, physics, 2019-12-01
The Lancet. Oncology, 2019-01
Molecular therapy : the journal of the American Society of Gene Therapy, 2018-11-07
Cancer immunology research, 2019-07
Br J Haematol, 2020 Mar 5
Lancet, 2020 Sep 01
Blood Adv,
Int J Radiat Oncol Biol Phys, 2020 May 22
The New England journal of medicine, 2017-12-28
Radiother Oncol, 2021 Dec 7
Int J Radiat Oncol Biol Phys, 2021 Dec 1
Clinical cancer research : an official journal of the American Association for Cancer Research, 2011-10-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015-01
Lung Cancer, 2020 Nov 13
Neuropathology, 2019 Mar 13
Respir Investig, 2014 Nov 13
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-07-01
International journal of radiation oncology, biology, physics, 1990-05
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-01-01
Ann Oncol,
Cancer, 2016-09-01
N. Engl. J. Med.,
N. Engl. J. Med.,
JAMA Oncol,
Ann Surg, 2021 Jul 16
The American journal of surgical pathology, 2008-01
Int J Part Ther, 2021 Jun 25
Annals of surgery, 2009-05
J Urol, 2021 Feb 26
Cancer,
BMC Cancer, 2020 Aug 12
Eur J Cancer, 2012 Nov 19
Lancet, 2021 Sep 20
The New England journal of medicine, 2004-09-02
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-07-01
J. Clin. Oncol., 2020 Sep 20
J Rheumatol, 2019 Apr 01
RMD Open,
Proceedings of the National Academy of Sciences of the United States of America, 2011-06-07
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017-01
European journal of nuclear medicine and molecular imaging, 2018-11
European urology oncology, 2018-05
J Nucl Med, 2021 Dec 16
J Nucl Med, 2018 Dec 14
Eur J Nucl Med Mol Imaging, 2019 Nov 15
Eur J Nucl Med Mol Imaging, 2019 Dec 26
JAMA Oncol,
J Urol, 2021 Feb 03
J Nucl Med, 2020 Jan 10
Clin Cancer Res, 2021 Feb 23
N. Engl. J. Med.,
J Clin Oncol, 2021 Jun 02
Int J Radiat Oncol Biol Phys, 2021 Nov 20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-06-01
Head & neck, 2014-05
Cancer, 2011 Feb 01
The Lancet. Oncology, 2013-04
Ann Surg,
Int J Radiat Oncol Biol Phys, 2021 Aug 01
J Clin Oncol, 2022 Jan 27
Int J Gynecol Cancer, 2020 Dec 18
N Engl J Med, 2021 Jun 23
Lancet, 2020 Sep 28
BMC cancer, 2019-06-13
Annals of Oncology, 2021 Sep 29
Cancer Cell, 2020 Oct 08
J Gen Intern Med, 2021 Feb 02
JAMA Netw Open, 2020 Jun 01
Practical radiation oncology, 2019-03
J Clin Oncol, 2022 Mar 15
N Engl J Med, 2021 Sep 18
N Engl J Med, 2022 Jan 19
Lancet Gastroenterol Hepatol, 2022 Feb 01
Prostate, 2022 Jun 08
Lancet, 2021 Jun 07
J Neurosurg, 2009 Aug
J Clin Oncol, 2020 Jul 24
Translational oncology, 2019-02
International journal of radiation oncology, biology, physics, 2006-07-15
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012-04
N Engl J Med,
N Engl J Med, 2022 Jun 05
J Natl Compr Canc Netw, 2021 Mar 24
N Engl J Med,
N Engl J Med, 2022 Jun 05
Lancet Oncol, 2014 Jul 31
N Engl J Med, 2022 Jun 04
J Clin Oncol, 2022 Jun 06
N Engl J Med, 2020 Sep 18
N. Engl. J. Med., 2019 Jun 02
J. Clin. Oncol., 2019 Jul 22
Lancet, 2021 Feb 11
Lancet Oncol, 2021 May 26
Clin Cancer Res, 2020 Oct 27
International journal of radiation oncology, biology, physics, 2014-03-01
BMC Cancer, 2021 May 27
N Engl J Med, 2022 Jun 03
J Clin Oncol, 2022 Jun 03
BMC Cancer, 2010 Aug 09
N Engl J Med,
J Nucl Med, 2021 Jun 24
Oncotarget, 2017 Feb 25
JAMA surgery, 2018-01-17
Lancet, 2020 Mar 05
BMC Cancer, 2020 Mar 18
Int J Surg Pathol, 2021 Jun 28
Breast Cancer Res Treat, 2020 Jul
JCO Oncol Pract, 2021 Aug
Eur. J. Cancer, 2015-03-01
Int J Radiat Oncol Biol Phys, 2022 Jul 04
International journal of radiation oncology, biology, physics, 2015-06-01
N Engl J Med, 2022 Apr 11
Lancet Oncol,
JAMA Oncol,
BJU Int, 2022 Apr 03
Int J Radiat Oncol Biol Phys, 2020 Sep 11
Lancet Oncol, 2022 Jan 17
Prostate Int, 2019 Feb 22
Arthritis care & research, 2018-10